Internet of Events
Leaderboard
Traders
Markets
Hot Bets
Surveillance
Pricing
Log in
Get Access
Accrue
/
Home
/
Manifold Markets
/
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
Manifold
Resolved: YES
BINARY · cpmm-1
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
Yes
71%
Yes Pool
$185
No Pool
$198
Resolution
YES